Clinical Trial Update: Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of caspofungin for invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Invasive Pulmonary Aspergillosis

Drugs mentioned

• Cancidas (caspofungin)

Snippet

Sponsor: The First Affiliated Hospital of Guangzhou Medical University | Conditions: Invasive Pulmonary Aspergillosis, Chronic Obstructive Pulmonary Disease | Phase 4 | Status: UNKNOWN